Physical data Gamma constant: 0.67 mrem/hr per mCi at 1 meter.
Because the spleen has one of the highest physiological uptakes, higher uptake and radiation dose to other organs or pathologic tissues may occur in patients with splenectomy. For an administered activity of 150 MBq (4.05 mCi) the typical radiation dose to the critical organs, which are the urinary bladder wall, the spleen and the kidneys/adrenals, are about 18, 16 and 12 mGy, respectively. The effective radiation dose resulting from the administration of 150 MBq (4.05 mCi) to an adult weighing 75 kg, is about 3.15 mSv. Gallium-68 decays with a half-life of 68 minutes to stable zinc Zn 68 10% through orbital electron capture (X-ray or Auger emissions), and 3% through 13 gamma transitions from 5 exited levels. This radioactive probe is used for diagnosing and staging to find Neuroendocrine tumors (NET) throughout the body. Ga 68 Dotatate injection, a radioactive diagnostic agent for positron emission tomography (PET) imaging. The supplies must have the following salient characteristics.
All Radiopharmaceutical Supplies shall be provided in accordance with the terms and conditions, and provisions of this solicitation for the base year period with the Government s option to extend the contract for four (4) additional one-year periods. VA Loma Linda Healthcare System is seeking to provide Radiopharmaceutical Supplies-NETSPOT (Gallium 68 Dotatate). Request for Information (RFI) should be submitted via email no later than 1pm PST Monday June 6th, 2022, to 2.
#Netspot gallium 68 dotatate plus
Period of Performance: Base year plus 4 options. Small Business Size Standard: 1250 employees 1.h. Applicable NAICS code: 325412, Pharmaceutical Preparation Manufacturing. Set Aside: This solicitation is issued as an unrestricted open market procurement. Solicitation Type - Number: Request for Quotes (RFQ) - 36C26222Q1022. Project Location: VA Loma Linda Healthcare System, 11201 Benton St, Loma Linda, CA 92357 1.d. Description: VA Loma Linda Healthcare System is seeking to provide Radiopharmaceutical Supplies-NETSPOT (Gallium 68 Dotatate). Project Title: Radiopharmaceutical Supplies-NETSPOT (Gallium 68 Dotatate). This announcement constitutes the only solicitation quotes are being requested and a separate written solicitation will not be issued. This is a combined synopsis/solicitation for commercial services/items prepared in accordance with the format in FAR Subpart 12.6 in conjunction with FAR Part 13, as supplemented with additional information included in this notice.
However, advances in treatment have made it possible for more and more patients to be accurately diagnosed, seek the most appropriate treatment, and live with the disease.1. This can lead to delays in diagnosis or even misdiagnosis and inappropriate treatment. Symptoms often resemble those of other diseases, like sweating, diarrhea, abdominal pain, and GI bleeding. They have become the second most common cancer of the gastrointestinal tract. There are several types of NETs, but most occur throughout the gastrointestinal tract and lungs. What are Neuroendocrine Tumors? Neuroendocrine Tumors (NETs) are a group of uncommon tumors. Gallium-68 dotatate (NETSPOT) is a new FDA-approved radiopharmaceutical test that makes Neuroendocrine Tumors visible on medical images for the purpose of accurate diagnosis and tracking. This scan helps accurately locate and characterize tumors in adult patients with somatostatin-receptor positive Neuroendocrine Tumors (NETs). What is NETSPOT (Gallium-68)? NETSPOT is the first Gallium-68 injection, a radioactive diagnostic agent for PET/CT imaging.
0 kommentar(er)
